several products made by nova nordisk. there is the $35 insulin cap that has already come into play. we have not talked about the $2000 out-of-pocket cap that will go into effect next year for medicare beneficiaries. a lot of things outside of the negotiation program that will be or are already affecting what beneficiaries pay at the counter or over a period of time. host: to that point, this text coming in from lee, part the medicare plans can change themularies at any time. if out-of-pocket costs are capped at 2000, what will stop the companies from dropping these drugs from their formularies? guest: the drugs are required to be covered on the formularies. what we don't know is where on the formularies. formularies at least in the private market typically change twice per year in january or july. we will not see the effects of this until 2026 so we still have a ways to go. where they are on the formularies, we will see. host: theresa in florida on the line for medicare beneficiaries. good morning. caller: hello c-span. t

nova nordisk the biggest company in europe is based upon projections of the ozempic it will sell to america. we have the food lobist have a bill in front of congress backed by the white house. backed by vice president harris and president biden to allow this to happen. $3 trillion will bankrupt our country. we for a fraction we could buy organic food for every american family three meals day and eliminate diabetes together. we'll bring healthy food back to school lunches. we'll stop subsidizing the worst foods with our agricultural subsidies. we'll get toxic chemicals out of our food. reform the entire food system and for that we need new leadership in washington. because unfortunately. both the democrats and the republican parties are in cohoots with big food companies. vice president harris expressed no interest in addressing this issue. four more years of democratic rule will complete the consolidation of corporate and neocon power and our children will be the ones who suffer most. i got involved with chronic disease 20 years ago, not because i chose to or wanted to. it was essential thr

several products made by nova nordisk.here is the $35 insulin cap that has already come into play. we have not talked about the $2000 out-of-pocket cap that will go into effect next year for medicare beneficiaries. a lot of things outside of the negotiation program that will be or are already affecting what beneficiaries pay at the counter or over a period of time. host: to that point, this text coming in from lee, the part the medicare pnsan change their formularies at any time. if out-of-pocket costs are capped at 2000, what will stop the companies from dropping these drugs from their formularies? guest: the drugs are required to be covered on the formularies. what we don't know is where on the formularies. formularies at least in the private market typically change twice per year in january or july. we will not see the effects of this until 2026 so we still have a ways to go. where they are on the formularies, we will see. host: theresa in florida on the line for medicare beneficiaries. good morning. caller: hello c-spa

several products made by nova nordisk.here is the $35 insulin cap that has already come into play. we have not talked about the $2000 out-of-pocket cap that will go into effect next year for medicare beneficiaries. a lot of things outside of the negotiation program that will be or are already affecting what beneficiaries pay at the counter or over a period of time. host: to that point, this text coming in from le the part the medar plans can change their formularies at any time. if out-of-pocket costs are capped at 2000, what will stop the companies from dropping these drugs from their formularies? guest: the drugs are required to be covered on the formularies. what we don't know is where on the formularies. formularies at least in the private market typically change twice per year in january or july. we will not see the effects of this until 2026 so we still have a ways to go. where they are on the formularies, we will see. host: theresa in florida on the line for medicare beneficiaries. good morning. caller: hello c-span